Blood test for monitoring metastatic colorectal cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study looks at a simple blood test to track colorectal cancer that has spread. It may allow doctors to monitor the cancer without needing repeated scans or biopsies, helping them adjust treatment more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with colorectal cancer (a type of cancer in the colon or rectum).
- The cancer has spread to other parts of the body (metastatic) or is too large to be removed with surgery.
- You are either about to start your first treatment for the metastatic cancer, or you have already started or completed it.
- If you have had previous chemotherapy or other treatments to shrink the tumor before surgery, those must have finished at least 6 months ago.
- If you are of childbearing potential, you are not pregnant and are not breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a blood test that looks for tiny bits of tumor DNA (ctDNA methylation) can help monitor how well treatment is working in people with colorectal cancer that has spread. If you are getting radiation and chemotherapy (with or without an immunotherapy drug), this trial may help your doctor see if the treatment is working sooner.
This study tests whether a simple blood test can track how well your colorectal cancer is responding to first-line chemotherapy. By monitoring cancer markers in your blood, doctors may be able to detect treatment changes earlier than traditional imaging.
This study tests if a simple blood test can help watch for cancer returning after surgery in people with colorectal cancer that has spread to other organs. It aims to improve follow-up care and help you feel more in control of your treatment.
This trial studies a simple blood test to learn more about early colorectal tumors. It may help doctors understand these tumors better and could lead to better care in the future.
This study looks at whether a simple blood test can help guide the care of people being evaluated for colorectal cancer. It may support earlier or clearer decision-making alongside existing screening or colonoscopy results.
This trial studies using a blood test to monitor how treatment is working in people with metastatic breast cancer. It may help your care team track your cancer over time with a simpler test.
Hear when a new Metastatic Colorectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.